Followers | 0 |
Posts | 2642 |
Boards Moderated | 0 |
Alias Born | 06/29/2013 |
Thursday, April 17, 2014 5:36:25 PM
CORAL SPRINGS, Fla., April 17, 2014 /PRNewswire/ -- Cyber Kiosk Solutions, Inc. (OTC Pink: CYBK), hereafter referred to as the "Company" or "CYBK" is pleased to announce that the Company has added DMH International President and CEO, Rik J. Deitsch, to its new Strategic Advisory Committee, formed to help navigate CYBK's expansion into several business verticals. The Company recently named Steven Machat, the head of LegalizePot.us, Inc., the first member of the committee.
Rik Deitsch, President and Chief Executive Officer, DMH International, (OTCQB: DMHI) has many years of entrepreneurial and executive management experience in health and life sciences companies. He founded Touch Medical Solutions (the operating Division of DMH International) in 2010 and has been the Chairman of the Board, President and CEO of the Company since December 31, 2012. From November 2002 through the present, Mr. Deitsch has served as the Chief Executive Officer of Nutra Pharma Corporation, a public biotechnology company with therapies for the treatment of Multiple Sclerosis, HIV and pain. Nutra Pharma markets OTC analgesics under the brand name Nyloxin. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom.
Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic. Mr. Deitsch has served as an adjunct professor and has taught several courses for Florida Atlantic University's College of Business and Continuing Education Department. Mr. Deitsch also teaches physician CME courses internationally, lecturing on lifestyle choices in the prevention and treatment of chronic disease states.
In addition, Mr. Deitsch has been the Chairman of Waiora's Scientific Advisory Board since April 2004. Waiora develops and markets natural, science-based dietary supplements and personal care products that provide healthy aging solutions. He is also the co-author of two books: Are You Age-Wise, a book that reviews current research in healthy aging as it relates to lifestyle choices and supplementation and Invisible Killers, a book that outlines our exposure to environmental toxins.
Chris Clarke, Chief Executive Officer of Cyber Kiosk Solutions, commented, "As the second committee member, Rik will be advising on sales and product distribution for our merchandising vertical, as well as providing strategic introductions through his solid network of contacts. His executive management and marketing background with public and private companies' products will undoubtedly be an asset to the Company, and will contribute to the growth of our brand, and the marketing and sales of our technology in the legalized marijuana market."
About Cyber Kiosk Solutions, Inc.:
Cyber Kiosk Solutions, Inc. (CYBK) has moved into several business vertical integrations and markets. The business verticals are; digital media, software and mobile application development, tablet POS systems and payment processing and merchandising and licensing of various unique products.
The Company has entered the legalized marijuana industry with its main focus on mobile apps, software integration and products to help aide in the responsible control measures that are expected to be implemented by various State and Government agencies throughout the next several years. The business plan is to work with dispensaries and various agencies to offer the Company's software and control measure products to aide in the responsible use of legalized marijuana. CYBK expects to position itself for credit card processing and will only turn on that feature in its mobile app after marijuana is removed from the federal government's controlled substance list and the laws allow for such transactions to take place legally.
CYBK has developed a unique closed loop products branding, licensing and launching distribution system that sets the Company ahead of the marketplace. The Company's use of its digital media platform will create additional exposure for its licensed and branded products.
CYBK is in the process of becoming the official and/or exclusive sales and marketing representative for several branded and unbranded products. CYBK seeks to purchase in whole or in part the companies that own these products. CYBK is looking to offer its products and services for sale on a global level.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
CONTACT:
Chris Clarke
investor@cyber-thingy.com
954-509-3748
SOURCE Cyber Kiosk Solutions, Inc.
Recent MONI News
- ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • InvestorsHub NewsWire • 06/05/2023 12:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM